<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d351" origId="Amitriptyline"><sentence id="DrugDDI.d351.s0" origId="s0" text="Drugs Metabolized by P450 2D6 - The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7-10% of caucasians are so called poor metabolizers);"><entity id="DrugDDI.d351.s0.e0" origId="s0.p0" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d351.s0.e1" origId="s0.p2" charOffset="21-30" type="drug" text="P450 2D6"/><entity id="DrugDDI.d351.s0.e2" origId="s0.p3" charOffset="64-68" type="drug" text="drug"/><entity id="DrugDDI.d351.s0.e3" origId="s0.p5" charOffset="111-135" type="drug" text="debrisoquin hydroxylase"/><pair id="DrugDDI.d351.s0.p0" e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e1" interaction="false"/><pair id="DrugDDI.d351.s0.p1" e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e2" interaction="false"/><pair id="DrugDDI.d351.s0.p2" e1="DrugDDI.d351.s0.e0" e2="DrugDDI.d351.s0.e3" interaction="false"/><pair id="DrugDDI.d351.s0.p3" e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e2" interaction="false"/><pair id="DrugDDI.d351.s0.p4" e1="DrugDDI.d351.s0.e1" e2="DrugDDI.d351.s0.e3" interaction="false"/><pair id="DrugDDI.d351.s0.p5" e1="DrugDDI.d351.s0.e2" e2="DrugDDI.d351.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d351.s1" origId="s1" text="reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."><entity id="DrugDDI.d351.s1.e0" origId="s1.p22" charOffset="48-65" type="drug" text="P450 2D6 isozyme"/></sentence><sentence id="DrugDDI.d351.s2" origId="s2" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses."><entity id="DrugDDI.d351.s2.e0" origId="s2.p33" charOffset="69-94" type="drug" text="tricyclic antidepressants"/></sentence><sentence id="DrugDDI.d351.s3" origId="s3" text="Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."><entity id="DrugDDI.d351.s3.e0" origId="s3.p41" charOffset="29-33" type="drug" text="drug"/><entity id="DrugDDI.d351.s3.e1" origId="s3.p43" charOffset="49-58" type="drug" text="P450 2D6"/><pair id="DrugDDI.d351.s3.p0" e1="DrugDDI.d351.s3.e0" e2="DrugDDI.d351.s3.e1" interaction="false"/></sentence><sentence id="DrugDDI.d351.s4" origId="s4" text="In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."><entity id="DrugDDI.d351.s4.e0" origId="s4.p57" charOffset="21-26" type="drug" text="drugs"/><entity id="DrugDDI.d351.s4.e1" origId="s4.p60" charOffset="56-63" type="drug" text="isozyme"/><pair id="DrugDDI.d351.s4.p0" e1="DrugDDI.d351.s4.e0" e2="DrugDDI.d351.s4.e1" interaction="true"/></sentence><sentence id="DrugDDI.d351.s5" origId="s5" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy."><entity id="DrugDDI.d351.s5.e0" origId="s5.p77" charOffset="112-117" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d351.s6" origId="s6" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine;"><entity id="DrugDDI.d351.s6.e0" origId="s6.p79" charOffset="4-9" type="drug" text="drugs"/><entity id="DrugDDI.d351.s6.e1" origId="s6.p82" charOffset="23-42" type="drug" text="cytochrome P450 2D6"/><entity id="DrugDDI.d351.s6.e2" origId="s6.p91" charOffset="96-105" type="drug" text="quinidine"/><pair id="DrugDDI.d351.s6.p0" e1="DrugDDI.d351.s6.e0" e2="DrugDDI.d351.s6.e1" interaction="false"/><pair id="DrugDDI.d351.s6.p1" e1="DrugDDI.d351.s6.e0" e2="DrugDDI.d351.s6.e2" interaction="false"/><pair id="DrugDDI.d351.s6.p2" e1="DrugDDI.d351.s6.e1" e2="DrugDDI.d351.s6.e2" interaction="false"/></sentence><sentence id="DrugDDI.d351.s7" origId="s7" text="cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."><entity id="DrugDDI.d351.s7.e0" origId="s7.p93" charOffset="0-10" type="drug" text="cimetidine"/><entity id="DrugDDI.d351.s7.e1" origId="s7.p100" charOffset="45-54" type="drug" text="P450 2D6"/><entity id="DrugDDI.d351.s7.e2" origId="s7.p102" charOffset="66-81" type="drug" text="antidepressants"/><entity id="DrugDDI.d351.s7.e3" origId="s7.p103" charOffset="83-97" type="drug" text="phenothiazines"/><entity id="DrugDDI.d351.s7.e4" origId="s7.p105" charOffset="131-142" type="drug" text="propafenone"/><entity id="DrugDDI.d351.s7.e5" origId="s7.p107" charOffset="147-157" type="drug" text="flecainide"/><pair id="DrugDDI.d351.s7.p0" e1="DrugDDI.d351.s7.e0" e2="DrugDDI.d351.s7.e1" interaction="false"/><pair id="DrugDDI.d351.s7.p1" e1="DrugDDI.d351.s7.e0" e2="DrugDDI.d351.s7.e2" interaction="false"/><pair id="DrugDDI.d351.s7.p2" e1="DrugDDI.d351.s7.e0" e2="DrugDDI.d351.s7.e3" interaction="false"/><pair id="DrugDDI.d351.s7.p3" e1="DrugDDI.d351.s7.e0" e2="DrugDDI.d351.s7.e4" interaction="false"/><pair id="DrugDDI.d351.s7.p4" e1="DrugDDI.d351.s7.e0" e2="DrugDDI.d351.s7.e5" interaction="false"/><pair id="DrugDDI.d351.s7.p5" e1="DrugDDI.d351.s7.e1" e2="DrugDDI.d351.s7.e2" interaction="false"/><pair id="DrugDDI.d351.s7.p6" e1="DrugDDI.d351.s7.e1" e2="DrugDDI.d351.s7.e3" interaction="false"/><pair id="DrugDDI.d351.s7.p7" e1="DrugDDI.d351.s7.e1" e2="DrugDDI.d351.s7.e4" interaction="false"/><pair id="DrugDDI.d351.s7.p8" e1="DrugDDI.d351.s7.e1" e2="DrugDDI.d351.s7.e5" interaction="false"/><pair id="DrugDDI.d351.s7.p9" e1="DrugDDI.d351.s7.e2" e2="DrugDDI.d351.s7.e3" interaction="false"/><pair id="DrugDDI.d351.s7.p10" e1="DrugDDI.d351.s7.e2" e2="DrugDDI.d351.s7.e4" interaction="false"/><pair id="DrugDDI.d351.s7.p11" e1="DrugDDI.d351.s7.e2" e2="DrugDDI.d351.s7.e5" interaction="false"/><pair id="DrugDDI.d351.s7.p12" e1="DrugDDI.d351.s7.e3" e2="DrugDDI.d351.s7.e4" interaction="false"/><pair id="DrugDDI.d351.s7.p13" e1="DrugDDI.d351.s7.e3" e2="DrugDDI.d351.s7.e5" interaction="false"/><pair id="DrugDDI.d351.s7.p14" e1="DrugDDI.d351.s7.e4" e2="DrugDDI.d351.s7.e5" interaction="false"/></sentence><sentence id="DrugDDI.d351.s8" origId="s8" text="While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."><entity id="DrugDDI.d351.s8.e0" origId="s8.p111" charOffset="24-53" type="drug" text="serotonin reuptake inhibitors"/><entity id="DrugDDI.d351.s8.e1" origId="s8.p118" charOffset="69-79" type="drug" text="fluoxetine"/><entity id="DrugDDI.d351.s8.e2" origId="s8.p119" charOffset="81-91" type="drug" text="sertraline"/><entity id="DrugDDI.d351.s8.e3" origId="s8.p121" charOffset="97-107" type="drug" text="paroxetine"/><entity id="DrugDDI.d351.s8.e4" origId="s8.p123" charOffset="117-126" type="drug" text="P450 2D6"/><pair id="DrugDDI.d351.s8.p0" e1="DrugDDI.d351.s8.e0" e2="DrugDDI.d351.s8.e1" interaction="false"/><pair id="DrugDDI.d351.s8.p1" e1="DrugDDI.d351.s8.e0" e2="DrugDDI.d351.s8.e2" interaction="false"/><pair id="DrugDDI.d351.s8.p2" e1="DrugDDI.d351.s8.e0" e2="DrugDDI.d351.s8.e3" interaction="false"/><pair id="DrugDDI.d351.s8.p3" e1="DrugDDI.d351.s8.e0" e2="DrugDDI.d351.s8.e4" interaction="true"/><pair id="DrugDDI.d351.s8.p4" e1="DrugDDI.d351.s8.e1" e2="DrugDDI.d351.s8.e2" interaction="false"/><pair id="DrugDDI.d351.s8.p5" e1="DrugDDI.d351.s8.e1" e2="DrugDDI.d351.s8.e3" interaction="false"/><pair id="DrugDDI.d351.s8.p6" e1="DrugDDI.d351.s8.e1" e2="DrugDDI.d351.s8.e4" interaction="false"/><pair id="DrugDDI.d351.s8.p7" e1="DrugDDI.d351.s8.e2" e2="DrugDDI.d351.s8.e3" interaction="false"/><pair id="DrugDDI.d351.s8.p8" e1="DrugDDI.d351.s8.e2" e2="DrugDDI.d351.s8.e4" interaction="true"/><pair id="DrugDDI.d351.s8.p9" e1="DrugDDI.d351.s8.e3" e2="DrugDDI.d351.s8.e4" interaction="false"/></sentence><sentence id="DrugDDI.d351.s9" origId="s9" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved."/><sentence id="DrugDDI.d351.s10" origId="s10" text="Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other."/><sentence id="DrugDDI.d351.s11" origId="s11" text="Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."><entity id="DrugDDI.d351.s11.e0" origId="s11.p164" charOffset="120-130" type="drug" text="fluoxetine"/><entity id="DrugDDI.d351.s11.e1" origId="s11.p169" charOffset="175-192" type="drug" text="active metabolite"/><pair id="DrugDDI.d351.s11.p0" e1="DrugDDI.d351.s11.e0" e2="DrugDDI.d351.s11.e1" interaction="false"/></sentence><sentence id="DrugDDI.d351.s12" origId="s12" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug."><entity id="DrugDDI.d351.s12.e0" origId="s12.p177" charOffset="19-44" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s12.e1" origId="s12.p178" charOffset="50-55" type="drug" text="drugs"/><entity id="DrugDDI.d351.s12.e2" origId="s12.p182" charOffset="73-92" type="drug" text="cytochrome P450 2D6"/><entity id="DrugDDI.d351.s12.e3" origId="s12.p190" charOffset="156-180" type="drug" text="tricyclic antidepressant"/><entity id="DrugDDI.d351.s12.e4" origId="s12.p192" charOffset="194-198" type="drug" text="drug"/><pair id="DrugDDI.d351.s12.p0" e1="DrugDDI.d351.s12.e0" e2="DrugDDI.d351.s12.e1" interaction="false"/><pair id="DrugDDI.d351.s12.p1" e1="DrugDDI.d351.s12.e0" e2="DrugDDI.d351.s12.e2" interaction="false"/><pair id="DrugDDI.d351.s12.p2" e1="DrugDDI.d351.s12.e0" e2="DrugDDI.d351.s12.e3" interaction="false"/><pair id="DrugDDI.d351.s12.p3" e1="DrugDDI.d351.s12.e0" e2="DrugDDI.d351.s12.e4" interaction="false"/><pair id="DrugDDI.d351.s12.p4" e1="DrugDDI.d351.s12.e1" e2="DrugDDI.d351.s12.e2" interaction="false"/><pair id="DrugDDI.d351.s12.p5" e1="DrugDDI.d351.s12.e1" e2="DrugDDI.d351.s12.e3" interaction="false"/><pair id="DrugDDI.d351.s12.p6" e1="DrugDDI.d351.s12.e1" e2="DrugDDI.d351.s12.e4" interaction="false"/><pair id="DrugDDI.d351.s12.p7" e1="DrugDDI.d351.s12.e2" e2="DrugDDI.d351.s12.e3" interaction="false"/><pair id="DrugDDI.d351.s12.p8" e1="DrugDDI.d351.s12.e2" e2="DrugDDI.d351.s12.e4" interaction="false"/><pair id="DrugDDI.d351.s12.p9" e1="DrugDDI.d351.s12.e3" e2="DrugDDI.d351.s12.e4" interaction="false"/></sentence><sentence id="DrugDDI.d351.s13" origId="s13" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."><entity id="DrugDDI.d351.s13.e0" origId="s13.p196" charOffset="41-46" type="drug" text="drugs"/><entity id="DrugDDI.d351.s13.e1" origId="s13.p201" charOffset="98-122" type="drug" text="tricyclic antidepressant"/><pair id="DrugDDI.d351.s13.p0" e1="DrugDDI.d351.s13.e0" e2="DrugDDI.d351.s13.e1" interaction="false"/></sentence><sentence id="DrugDDI.d351.s14" origId="s14" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be coadministered with another drug known to be an inhibitor of P450 2D6."><entity id="DrugDDI.d351.s14.e0" origId="s14.p217" charOffset="103-107" type="drug" text="drug"/><entity id="DrugDDI.d351.s14.e1" origId="s14.p222" charOffset="136-145" type="drug" text="P450 2D6"/><pair id="DrugDDI.d351.s14.p0" e1="DrugDDI.d351.s14.e0" e2="DrugDDI.d351.s14.e1" interaction="false"/></sentence><sentence id="DrugDDI.d351.s15" origId="s15" text="Monoamine Oxidase Inhibitors: Guanethidine or similarly acting compounds;"><entity id="DrugDDI.d351.s15.e0" origId="s15.p223" charOffset="0-28" type="drug" text="Monoamine Oxidase Inhibitors"/><entity id="DrugDDI.d351.s15.e1" origId="s15.p225" charOffset="30-42" type="drug" text="Guanethidine"/><pair id="DrugDDI.d351.s15.p0" e1="DrugDDI.d351.s15.e0" e2="DrugDDI.d351.s15.e1" interaction="false"/></sentence><sentence id="DrugDDI.d351.s16" origId="s16" text="thyroid medication;"><entity id="DrugDDI.d351.s16.e0" origId="s16.p229" charOffset="0-18" type="drug" text="thyroid medication"/></sentence><sentence id="DrugDDI.d351.s17" origId="s17" text="alcohol, barbiturates and other CNS depressants;"><entity id="DrugDDI.d351.s17.e0" origId="s17.p231" charOffset="0-7" type="drug" text="alcohol"/><entity id="DrugDDI.d351.s17.e1" origId="s17.p232" charOffset="9-21" type="drug" text="barbiturates"/><entity id="DrugDDI.d351.s17.e2" origId="s17.p234" charOffset="32-47" type="drug" text="CNS depressants"/><pair id="DrugDDI.d351.s17.p0" e1="DrugDDI.d351.s17.e0" e2="DrugDDI.d351.s17.e1" interaction="false"/><pair id="DrugDDI.d351.s17.p1" e1="DrugDDI.d351.s17.e0" e2="DrugDDI.d351.s17.e2" interaction="false"/><pair id="DrugDDI.d351.s17.p2" e1="DrugDDI.d351.s17.e1" e2="DrugDDI.d351.s17.e2" interaction="false"/></sentence><sentence id="DrugDDI.d351.s18" origId="s18" text="and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required."><entity id="DrugDDI.d351.s18.e0" origId="s18.p237" charOffset="4-14" type="drug" text="disulfiram"/><entity id="DrugDDI.d351.s18.e1" origId="s18.p239" charOffset="20-37" type="drug" text="amitriptyline HCl"/><entity id="DrugDDI.d351.s18.e2" origId="s18.p242" charOffset="52-74" type="drug" text="anticholinergic agents"/><entity id="DrugDDI.d351.s18.e3" origId="s18.p244" charOffset="78-99" type="drug" text="sympathomimetic drugs"/><entity id="DrugDDI.d351.s18.e4" origId="s18.p246" charOffset="111-122" type="drug" text="epinephrine"/><entity id="DrugDDI.d351.s18.e5" origId="s18.p248" charOffset="137-154" type="drug" text="local anesthetics"/><pair id="DrugDDI.d351.s18.p0" e1="DrugDDI.d351.s18.e0" e2="DrugDDI.d351.s18.e1" interaction="false"/><pair id="DrugDDI.d351.s18.p1" e1="DrugDDI.d351.s18.e0" e2="DrugDDI.d351.s18.e2" interaction="false"/><pair id="DrugDDI.d351.s18.p2" e1="DrugDDI.d351.s18.e0" e2="DrugDDI.d351.s18.e3" interaction="false"/><pair id="DrugDDI.d351.s18.p3" e1="DrugDDI.d351.s18.e0" e2="DrugDDI.d351.s18.e4" interaction="false"/><pair id="DrugDDI.d351.s18.p4" e1="DrugDDI.d351.s18.e0" e2="DrugDDI.d351.s18.e5" interaction="false"/><pair id="DrugDDI.d351.s18.p5" e1="DrugDDI.d351.s18.e1" e2="DrugDDI.d351.s18.e2" interaction="false"/><pair id="DrugDDI.d351.s18.p6" e1="DrugDDI.d351.s18.e1" e2="DrugDDI.d351.s18.e3" interaction="false"/><pair id="DrugDDI.d351.s18.p7" e1="DrugDDI.d351.s18.e1" e2="DrugDDI.d351.s18.e4" interaction="false"/><pair id="DrugDDI.d351.s18.p8" e1="DrugDDI.d351.s18.e1" e2="DrugDDI.d351.s18.e5" interaction="false"/><pair id="DrugDDI.d351.s18.p9" e1="DrugDDI.d351.s18.e2" e2="DrugDDI.d351.s18.e3" interaction="false"/><pair id="DrugDDI.d351.s18.p10" e1="DrugDDI.d351.s18.e2" e2="DrugDDI.d351.s18.e4" interaction="false"/><pair id="DrugDDI.d351.s18.p11" e1="DrugDDI.d351.s18.e2" e2="DrugDDI.d351.s18.e5" interaction="false"/><pair id="DrugDDI.d351.s18.p12" e1="DrugDDI.d351.s18.e3" e2="DrugDDI.d351.s18.e4" interaction="false"/><pair id="DrugDDI.d351.s18.p13" e1="DrugDDI.d351.s18.e3" e2="DrugDDI.d351.s18.e5" interaction="false"/><pair id="DrugDDI.d351.s18.p14" e1="DrugDDI.d351.s18.e4" e2="DrugDDI.d351.s18.e5" interaction="false"/></sentence><sentence id="DrugDDI.d351.s19" origId="s19" text="Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather."><entity id="DrugDDI.d351.s19.e0" origId="s19.p260" charOffset="36-53" type="drug" text="amitriptyline HCl"/><entity id="DrugDDI.d351.s19.e1" origId="s19.p263" charOffset="75-97" type="drug" text="anticholinergic agents"/><entity id="DrugDDI.d351.s19.e2" origId="s19.p265" charOffset="106-123" type="drug" text="neuroleptic drugs"/><pair id="DrugDDI.d351.s19.p0" e1="DrugDDI.d351.s19.e0" e2="DrugDDI.d351.s19.e1" interaction="true"/><pair id="DrugDDI.d351.s19.p1" e1="DrugDDI.d351.s19.e0" e2="DrugDDI.d351.s19.e2" interaction="false"/><pair id="DrugDDI.d351.s19.p2" e1="DrugDDI.d351.s19.e1" e2="DrugDDI.d351.s19.e2" interaction="false"/></sentence><sentence id="DrugDDI.d351.s20" origId="s20" text="Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic-type drugs."><entity id="DrugDDI.d351.s20.e0" origId="s20.p273" charOffset="45-70" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s20.e1" origId="s20.p275" charOffset="91-117" type="drug" text="anticholinergic-type drugs"/><pair id="DrugDDI.d351.s20.p0" e1="DrugDDI.d351.s20.e0" e2="DrugDDI.d351.s20.e1" interaction="true"/></sentence><sentence id="DrugDDI.d351.s21" origId="s21" text="Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs."><entity id="DrugDDI.d351.s21.e0" origId="s21.p276" charOffset="0-10" type="drug" text="Cimetidine"/><entity id="DrugDDI.d351.s21.e1" origId="s21.p282" charOffset="63-88" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s21.e2" origId="s21.p288" charOffset="171-176" type="drug" text="drugs"/><pair id="DrugDDI.d351.s21.p0" e1="DrugDDI.d351.s21.e0" e2="DrugDDI.d351.s21.e1" interaction="true"/><pair id="DrugDDI.d351.s21.p1" e1="DrugDDI.d351.s21.e0" e2="DrugDDI.d351.s21.e2" interaction="false"/><pair id="DrugDDI.d351.s21.p2" e1="DrugDDI.d351.s21.e1" e2="DrugDDI.d351.s21.e2" interaction="false"/></sentence><sentence id="DrugDDI.d351.s22" origId="s22" text="Clinically significant effects have been reported with the tricyclic antidepressants when used concomitantly with cimetidine."><entity id="DrugDDI.d351.s22.e0" origId="s22.p293" charOffset="59-84" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s22.e1" origId="s22.p297" charOffset="114-124" type="drug" text="cimetidine"/><pair id="DrugDDI.d351.s22.p0" e1="DrugDDI.d351.s22.e0" e2="DrugDDI.d351.s22.e1" interaction="true"/></sentence><sentence id="DrugDDI.d351.s23" origId="s23" text="Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen."><entity id="DrugDDI.d351.s23.e0" origId="s23.p300" charOffset="30-55" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s23.e1" origId="s23.p306" charOffset="121-136" type="drug" text="anticholinergic"/><entity id="DrugDDI.d351.s23.e2" origId="s23.p311" charOffset="162-172" type="drug" text="cimetidine"/><entity id="DrugDDI.d351.s23.e3" origId="s23.p314" charOffset="190-194" type="drug" text="drug"/><pair id="DrugDDI.d351.s23.p0" e1="DrugDDI.d351.s23.e0" e2="DrugDDI.d351.s23.e1" interaction="false"/><pair id="DrugDDI.d351.s23.p1" e1="DrugDDI.d351.s23.e0" e2="DrugDDI.d351.s23.e2" interaction="true"/><pair id="DrugDDI.d351.s23.p2" e1="DrugDDI.d351.s23.e0" e2="DrugDDI.d351.s23.e3" interaction="false"/><pair id="DrugDDI.d351.s23.p3" e1="DrugDDI.d351.s23.e1" e2="DrugDDI.d351.s23.e2" interaction="false"/><pair id="DrugDDI.d351.s23.p4" e1="DrugDDI.d351.s23.e1" e2="DrugDDI.d351.s23.e3" interaction="false"/><pair id="DrugDDI.d351.s23.p5" e1="DrugDDI.d351.s23.e2" e2="DrugDDI.d351.s23.e3" interaction="false"/></sentence><sentence id="DrugDDI.d351.s24" origId="s24" text="Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants."><entity id="DrugDDI.d351.s24.e0" origId="s24.p316" charOffset="19-29" type="drug" text="cimetidine"/><entity id="DrugDDI.d351.s24.e1" origId="s24.p319" charOffset="68-93" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d351.s24.e2" origId="s24.p321" charOffset="98-108" type="drug" text="cimetidine"/><entity id="DrugDDI.d351.s24.e3" origId="s24.p327" charOffset="160-175" type="drug" text="antidepressants"/><pair id="DrugDDI.d351.s24.p0" e1="DrugDDI.d351.s24.e0" e2="DrugDDI.d351.s24.e1" interaction="false"/><pair id="DrugDDI.d351.s24.p1" e1="DrugDDI.d351.s24.e0" e2="DrugDDI.d351.s24.e2" interaction="false"/><pair id="DrugDDI.d351.s24.p2" e1="DrugDDI.d351.s24.e0" e2="DrugDDI.d351.s24.e3" interaction="false"/><pair id="DrugDDI.d351.s24.p3" e1="DrugDDI.d351.s24.e1" e2="DrugDDI.d351.s24.e2" interaction="true"/><pair id="DrugDDI.d351.s24.p4" e1="DrugDDI.d351.s24.e1" e2="DrugDDI.d351.s24.e3" interaction="false"/><pair id="DrugDDI.d351.s24.p5" e1="DrugDDI.d351.s24.e2" e2="DrugDDI.d351.s24.e3" interaction="false"/></sentence><sentence id="DrugDDI.d351.s25" origId="s25" text="Caution is advised if patients receive large doses of ethchlorvynol concurrently."><entity id="DrugDDI.d351.s25.e0" origId="s25.p334" charOffset="54-68" type="drug" text="ethchlorvynol"/></sentence><sentence id="DrugDDI.d351.s26" origId="s26" text="Transient delirium has been reported in patients who were treated with one gram of ethchlorvynol and 75 - 150 mg of amitriptyline HCl."><entity id="DrugDDI.d351.s26.e0" origId="s26.p344" charOffset="83-97" type="drug" text="ethchlorvynol"/><entity id="DrugDDI.d351.s26.e1" origId="s26.p347" charOffset="116-133" type="drug" text="amitriptyline HCl"/><pair id="DrugDDI.d351.s26.p0" e1="DrugDDI.d351.s26.e0" e2="DrugDDI.d351.s26.e1" interaction="true"/></sentence></document>